Additional, these inhibitors have been found with mood adverse effects, raising the concerns about the safety and need further investigative efforts in breast cancer therapy.506 Till now, several PI3K pathway inhibitors are reported in the clinical trials for various cancers. This evidence concerns the gene PIK3CA and breast cancer.